To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).

NCT03731091 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

494

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis Vulgaris

Interventions

DRUG: Calcipotriene/ betamethasone dipropionate topical foam, 0.005%/0.064%
DRUG: Enstilar® foam (LEO Pharma Inc.)
OTHER: Placebo of Calcipotriene/ betamethasone dipropionate topical foam

Sponsor

Glenmark Pharmaceuticals Ltd. India